中文 | English
Return
Total: 10 , 1/1
Show Home Prev Next End page: GO
MeSH:(HIV Envelope Protein gp41/*chemistry)

1.The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects.

Huan LIU ; Xiaojie SU ; Lulu SI ; Lu LU ; Shibo JIANG

Protein & Cell 2018;9(7):596-615

2.Inhibitory effect of polysaccharides on the six-alpha-helix bundle formation of HIV gp41 protein.

Xiao-Yun WEN ; Shao-Yu WU ; Wei XU ; Li LV ; Shu-Wen LIU ; Jin-Jun RAO ; Jia-Jie ZHANG ; Guang-Fa WANG ; Shan-He WAN ; Shu-Guang WU

Journal of Southern Medical University 2007;27(10):1498-1500

3.Expression, structure and antigenicity analysis of N51 derived from the N-terminal heptad repeat domain in gp41 of HIV-1 CRF07_BC strain.

Jiping SHAO ; Shibo JIANG ; Shuwen LIU

Journal of Southern Medical University 2012;32(12):1737-1740

4.A non-infectious and quantitative cell-based bioassay for screening HIV entry inhibitors targeting HIV envelope proteins.

Min-min LI ; Cheng-lai XIA ; Qin-chao MAO ; Shi-bo JIANG ; Shu-wen LIU

Journal of Southern Medical University 2010;30(5):941-944

5.Conserved arginine residue in the membrane-spanning domain of HIV-1 gp41 is required for efficient membrane fusion.

Yufei LONG ; Fanxia MENG ; Naoyuki KONDO ; Aikichi IWAMOTO ; Zene MATSUDA

Protein & Cell 2011;2(5):369-376

6.The current progress in the development of HIV-1 fusion inhibitors.

Wei-guo SHI ; Qi-yan JIA ; Ke-liang LIU

Acta Pharmaceutica Sinica 2010;45(2):184-193

7.Structure-activity relationships of anti-HIV-1 peptides with disulfide linkage between D- and L-cysteine at positions i and i+3, respectively, derived from HIV-1 gp41 C-peptide.

Myung Kyu LEE ; Hee Kyung KIM ; Tae Young LEE ; Kyung Soo HAHM ; Kil Lyong KIM

Experimental & Molecular Medicine 2006;38(1):18-26

8.HIV entry inhibitors: progress in development and application.

Wei-hong LAI ; Li HUANG ; Chin-ho CHEN

Acta Pharmaceutica Sinica 2010;45(2):131-140

9.Association of variations of NAb 2F5 and 4E10 epitopes and disease progression in Chinese antiretroviral treatment-naïve patients infected with HIV-1 clade B'.

Xiao-Li ZHANG ; Xiao-Xu HAN ; Di DAI ; Ming-Jia BAO ; Dong-Bing XU ; Zi-Ning ZHANG ; Ya-Nan WANG ; Min ZHAO ; Tristan BICE ; Yong-Jun JIANG ; Hong SHANG

Chinese Medical Journal 2010;123(23):3406-3411

10.The newest developments in anti-HIV-1 drugs.

Xing-quan ZHANG

Acta Pharmaceutica Sinica 2010;45(2):194-204

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 10 , 1/1 Show Home Prev Next End page: GO